BioCryst Pharmaceuticals | BCRX - هزینه PE به سود





Pe تغییر دادن تاریخ
Alnylam Pharmaceuticals 170.7 367.33 2025-12
BioCryst Pharmaceuticals 6.06 1.07K 2025-12
Chugai Pharma 31.26 5.24 2025-12
Daiichi Sankyo 20.73 1.74 2025-12
Gilead Sciences 15.63 0.08 2025-12
GlaxoSmithKline 11.15 0.29 2025-12
Glaxosmithkline 11.66 0.28 2025-12
Incyte 14.84 2.79 2025-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
Neurocrine Biosciences 835.47 802.2 2025-12
Novavax 2.01 1.07 2025-12
PTC Therapeutics 9.98 3.25 2025-12
Regeneron Pharmaceuticals 18.11 2.91 2025-12
Roche Holding 16.09 3.51 2025-12
Sarepta Therapeutics 27.27 0 2025-09
Vertex Pharmaceuticals 26.15 2.22 2025-12